You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sorafenib

Showing 26 - 50 of 320
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Leukemia, Relapse, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (Sorafenib)

Recruiting
  • Acute Leukemia
  • +2 more
  • Sorafenib
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 30, 2021

BCLC Stage C Hepatocellular Carcinoma Trial in Hangzhou (TACE, Tilelizumab, Sorafenib)

Not yet recruiting
  • BCLC Stage C Hepatocellular Carcinoma
  • TACE
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Aug 10, 2021

Hepatocellular Carcinoma Trial in United States (BBI608, BBI503, Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Gilbert, Arizona
  • +28 more
Apr 4, 2022

Metastatic Breast Cancer Trial in United States (Sorafenib, Letrozole)

Terminated
  • Metastatic Breast Cancer
  • Washington, District of Columbia
  • +3 more
Sep 21, 2021

Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Richmond (drug, radiation, other)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Oct 20, 2021

Hepatocellular Cancer, Liver Cancer Trial in Tampa (Trametinib, Sorafenib)

Completed
  • Hepatocellular Cancer
  • Liver Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 9, 2021

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Baltimore (Bone Marrow Transplantation, Sorafenib, Sorafenib Tosylate)

Completed
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Bone Marrow Transplantation
  • +2 more
  • Baltimore, Maryland
  • +1 more
May 27, 2021

Metastatic Renal Cell Carcinoma Trial in Italy (sorafenib)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • sorafenib
  • Milan, Mi, Italy
  • +13 more
Sep 16, 2021

Hepatocellular Carcinoma Trial in Shanghai (Toripalimab, Sorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Zhongshan Hospital
Jun 14, 2021

Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023

Hepatocellular Cancer Trial in Shanghai (hepatic resection, Sorafenib)

Recruiting
  • Hepatocellular Cancer
  • hepatic resection
  • Sorafenib
  • Shanghai, China
    Eastern Hepatobiliary Surgery Hospital
Apr 8, 2021

Hepatocellular Carcinoma Trial in Worldwide (Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Sorafenib
  • Tucson, Arizona
  • +23 more
Apr 16, 2021

Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Radiotherapy, Toripalimab, Sorafenib Trial in Beijing (Radiotherapy plus Toripalimab, Sorafenib)

Recruiting
  • Radiotherapy
  • +3 more
  • Radiotherapy plus Toripalimab
  • Sorafenib
  • Beijing, Beijing, China
    Bo Chen
Mar 6, 2021

Hepatocellular Carcinoma Trial in Hangzhou (Sorafenib, S-1, Oxaliplatin)

Withdrawn
  • Hepatocellular Carcinoma
  • Sorafenib
  • +2 more
  • Hangzhou, China
    First affiliated hospital, Zhejiang University
Feb 12, 2021

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Carcinoma, Hepatocellular Trial in Navi Mumbai (radiation, procedure, drug)

Recruiting
  • Carcinoma, Hepatocellular
  • SBRT
  • +2 more
  • Navi Mumbai, Maharashtra, India
  • +1 more
Apr 25, 2022

Hepatocellular Carcinoma Trial in Shanghai (Sintilimab, IBI305, Sorafenib)

Unknown status
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Hospital of Fudan University
Jan 21, 2021

Advanced Hepatocellular Carcinoma, Liver Cancer, Hepatic Cancer Trial in Worldwide (CS-1008 2 mg/kg, Sorafenib, CS-1008 6/2

Completed
Has Results
  • Advanced Hepatocellular Carcinoma
  • +3 more
  • CS-1008 2 mg/kg
  • +5 more
  • Los Angeles, California
  • +27 more
Apr 6, 2021

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Clinically Significant Portal Hypertension Trial in United States (Placebo, Sorafenib)

Completed
Has Results
  • Clinically Significant Portal Hypertension
  • Placebo
  • Sorafenib
  • New Haven, Connecticut
  • +5 more
Dec 2, 2020

Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (HAIC of FOLFOX, Sorafenib)

Unknown status
  • Hepatocellular Carcinoma
  • HAIC of FOLFOX
  • Sorafenib
  • Guangzhou, Guangdong, China
  • +2 more
Dec 3, 2020

Advanced Hepatocellular Carcinoma (HCC) Trial in China, Singapore (Toripalimab combined with Bevacizumab, Sorafenib)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • Toripalimab combined with Bevacizumab
  • Sorafenib
  • Bengbu, Anhui, China
  • +55 more
Jun 22, 2022